BRIEF published on 04/01/2026 at 06:35, 6 months 7 days ago Lonza annonce les détails de son assemblée générale annuelle 2026 et publie ses rapports 2025. Proposition De Dividende Changements Au Conseil D'administration Efforts De Développement Durable Rapport Annuel 2025 Assemblée Générale Annuelle De 2026
BRIEF published on 04/01/2026 at 06:35, 6 months 7 days ago Lonza Announces 2026 AGM Details and Publishes 2025 Reports Board Changes Dividend Proposal Sustainability Efforts 2025 Annual Report 2026 AGM
PRESS RELEASE published on 04/01/2026 at 06:30, 6 months 7 days ago Lonza Publishes 2026 Annual General Meeting Invitation and 2025 Annual and Sustainability Reports Lonza publishes 2026 AGM invitation and 2025 Annual and Sustainability Reports. Board changes and dividend increase announced Dividend Increase Lonza Annual Report Sustainability Report 2026 AGM
BRIEF published on 03/31/2026 at 14:05, 6 months 7 days ago Lonza nomme Stephen Fry membre indépendant du conseil d'administration Gouvernance Industrie Pharmaceutique Transformation Organisationnelle Conseil D'administration De Lonza Stephen Fry
BRIEF published on 03/31/2026 at 14:05, 6 months 7 days ago Lonza Nominates Stephen Fry as Independent Board Member Pharmaceutical Industry Governance Organizational Transformation Lonza Board Stephen Fry
PRESS RELEASE published on 03/31/2026 at 14:00, 6 months 7 days ago Lonza Nominates Stephen Fry as Independent Board Member Lonza nominates Stephen Fry, with extensive pharma industry track record, as Independent Board Member. Fry to join Lonza AGM in May 2026 Lonza AGM Board Member Pharma Industry Stephen Fry
BRIEF published on 03/09/2026 at 14:05, 6 months 29 days ago Lonza et Genetix prolongent leur accord de fabrication pour ZYNTEGLO™ Lonza Thérapie Génique Accord De Fabrication ZYNTEGLO™ Génétique
BRIEF published on 03/09/2026 at 14:05, 6 months 29 days ago Lonza and Genetix Extend Manufacturing Agreement for ZYNTEGLO™ Lonza Gene Therapy Manufacturing Agreement Genetix ZYNTEGLO™
PRESS RELEASE published on 03/09/2026 at 14:00, 6 months 29 days ago Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO™ Lonza and Genetix extend commercial manufacturing agreement for ZYNTEGLO™, the FDA-approved gene therapy for beta-thalassemia patients Lonza Gene Therapy Manufacturing Agreement Genetix ZYNTEGLO
BRIEF published on 03/06/2026 at 18:10, 7 months 1 day ago Lonza to Divest Capsules & Health Ingredients Unit, Enhancing CDMO Focus CDMO Lonza Divestment Strategic Transformation CHI Sale
Published on 10/07/2026 at 23:30, 7 hours 13 minutes ago Algo Grande Copper Core Testing Shows Mineralized Skarn is Denser and More Chargeable Than Host Rocks; Ground Gravity Survey to Begin at Adelita
Published on 10/07/2026 at 22:05, 8 hours 38 minutes ago Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 13 hours 43 minutes ago BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 15 hours 13 minutes ago Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 16 hours 13 minutes ago Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/08/2026 at 06:05, 37 minutes ago The Art Basel and UBS Survey of Global Collecting 2026 reveals Gen Z as the highest-spending generation
Published on 10/07/2026 at 23:30, 7 hours 12 minutes ago Acuity Analytics expands US data and technology capabilities with acquisition of Continuus
Published on 10/07/2026 at 23:20, 7 hours 22 minutes ago BAR LEONE, HONG KONG, IS THE WORLD'S BEST BAR AS THE LIST OF THE 50 BEST BARS 2026 IS REVEALED
Published on 10/07/2026 at 22:00, 8 hours 42 minutes ago Invitation - Q3 2026 Trading Update Conference Call
Published on 10/07/2026 at 21:35, 9 hours 7 minutes ago OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry
Published on 10/07/2026 at 20:15, 10 hours 27 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 10 hours 28 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 10 hours 28 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 20:15, 10 hours 28 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 18:19, 12 hours 23 minutes ago Outstanding shares and voting rights statement at 30 September 2026
